You have to change habits and eat sweets and sugar in moderation. Incorporating more protein, fiber and healthy fats can help boost your nutritional needs
GLP-1RA therapy, when prolonged and potent, may lead to a form of iatrogenic ERM : Short-term gains: lower glucose, lower weight, lower cardiovascular risk Long-term risks: impaired amino-acid balance, reduced re-anabolism, muscle loss, frailty, diminished resilience This progression can be subtle and clinically silentbiochemically detectable long before symptoms appear
But like all medications, it comes with side effects
The hypoglycaemia risk is primarily with insulin or sulphonylureas, as GLP-1 receptor agonists alone rarely cause hypoglycaemia
A., Dicker, D., & STEP 4 Investigators